Literature DB >> 32578226

Screening, assessment and management of type 2 diabetes mellitus in children and adolescents: Australasian Paediatric Endocrine Group guidelines.

Alexia S Peña1,2, Jacqueline A Curran3, Michelle Fuery4, Catherine George3, Craig A Jefferies5, Kristine Lobley6, Karissa Ludwig7, Ann M Maguire6,8, Emily Papadimos4,9, Aimee Peters6, Fiona Sellars4, Jane Speight10,11, Angela Titmuss9,12, Dyanne Wilson13, Jencia Wong8,14, Caroline Worth5, Rachana Dahiya4,15.   

Abstract

INTRODUCTION: The incidence of type 2 diabetes mellitus has increased in children and adolescents due largely to the obesity epidemic, particularly in high risk ethnic groups. β-Cell function declines faster and diabetes complications develop earlier in paediatric type 2 diabetes compared with adult-onset type 2 diabetes. There are no consensus guidelines in Australasia for assessment and management of type 2 diabetes in paediatric populations and health professionals have had to refer to adult guidelines. Recent international paediatric guidelines did not address adaptations to care for patients from Indigenous backgrounds. MAIN RECOMMENDATIONS: This guideline provides advice on paediatric type 2 diabetes in relation to screening, diagnosis, diabetes education, monitoring including targets, multicomponent healthy lifestyle, pharmacotherapy, assessment and management of complications and comorbidities, and transition. There is also a dedicated section on considerations of care for children and adolescents from Indigenous background in Australia and New Zealand. CHANGES IN MANAGEMENT AS A RESULT OF THE GUIDELINES: Published international guidelines currently exist, but the challenges and specifics to care for children and adolescents with type 2 diabetes which should apply to Australasia have not been addressed to date. These include: recommendations regarding care of children and adolescents from Indigenous backgrounds in Australia and New Zealand including screening and management; tighter diabetes targets (glycated haemoglobin, ≤ 48 mmol/mol [≤ 6.5%]) for all children and adolescents; considering the use of newer medications approved for adults with type 2 diabetes under the guidance of a paediatric endocrinologist; and the need to transition adolescents with type 2 diabetes to a diabetes multidisciplinary care team including an adult endocrinologist for their ongoing care.
© 2020 AMPCo Pty Ltd.

Entities:  

Keywords:  Adolescence; Childhood diseases; Diabetes mellitus, type 2; Indigenous health; Social determinants of health

Year:  2020        PMID: 32578226     DOI: 10.5694/mja2.50666

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

Review 1.  Current Perspectives on the Role of Very-Low-Energy Diets in the Treatment of Obesity and Type 2 Diabetes in Youth.

Authors:  Megan L Gow; Anna Pham-Short; Hiba Jebeile; Benjamin J Varley; Maria E Craig
Journal:  Diabetes Metab Syndr Obes       Date:  2021-01-18       Impact factor: 3.168

Review 2.  Criteria for Diagnosis of Polycystic Ovary Syndrome during Adolescence: Literature Review.

Authors:  Alexia S Peña; Ethel Codner; Selma Witchel
Journal:  Diagnostics (Basel)       Date:  2022-08-10

Review 3.  Teucrium polium: Potential Drug Source for Type 2 Diabetes Mellitus.

Authors:  Yaser Albadr; Andrew Crowe; Rima Caccetta
Journal:  Biology (Basel)       Date:  2022-01-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.